Last updated: 2026-09-09 04:29:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Bioventus Inc. (BVS) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $13.84, with a market capitalization of $961.05M and a P/E ratio of 16.79. Over the past 52 weeks, its price has ranged from $6.26 to $15.89. This page covers its latest market performance, valuation, price trends and company information.
$961.05M | |
$14.04 | |
$25.94 | |
$0.80 | |
$14.07 | |
390.50K | |
707.19K | |
16.79 | |
$15.89 | |
$6.26 | |
-- | |
-- |
Bioventus Inc. (BVS) last closed at $14.07 as of 2026-09-08 23:48:00, unchanged from the previous close of $14.07.
During the latest regular trading session, BVS traded between $0.80 and $25.94, with a volume of 390.50K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, Bioventus Inc. (BVS) moved from $13.79 to $13.84, representing a gain of 0.36% ($0.05).
The stock traded between $13.44 and $14.50 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 553.97 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 78.7%
BVS is currently trading at $13.84, placing it 78.7% of the way from its 52-week low of $6.26 to its 52-week high of $15.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 950 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bioventus Inc. (BVS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.